15 Mar Mutant antigen may improve meningitis vaccine development
Paul Tinder, VaccineNews Daily.com
A study conducted by the University of Massachusetts Medical Center and the Children’s Hospital & Research Center Oakland has identified a new mutant vaccine antigen that may improve the development of an effective meningitis vaccine.
Meningococci are the bacteria that cause meningitis and other severe infections of the bloodstream. These infections are dangerous to children and teenagers. Around 10 percent of the infected may not survive while 20 percent are left with long-term medical problems.